A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
Phase 1 trials (9)
Other trials (5)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (9)